Prognostic significance of NAB2–STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors/hemangiopericytomas of the CNS: not (yet) clear

Dutch CNS SFT/HPC Consortium; French CNS SFT/HPC Consortium

doi:https://doi.org/10.1007/s00401-019-01968-3

Prognostic significance of NAB2–STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors/hemangiopericytomas of the CNS: not (yet) clear

DSpace/Manakin Repository

Prognostic significance of NAB2–STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors/hemangiopericytomas of the CNS: not (yet) clear

Dutch CNS SFT/HPC Consortium; French CNS SFT/HPC Consortium

(2019) Acta Neuropathologica, volume 137, issue 4, pp. 679 - 682

(Comment)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Pathology and Forensic Medicine, Clinical Neurology, Cellular and Molecular Neuroscience

DOI: https://doi.org/10.1007/s00401-019-01968-3

ISSN: 0001-6322

Publisher: Springer

Note: Funding Information: Acknowledgements This study was performed with a supporting research grant from the Stichting STOP Hersentumoren, the Netherlands. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

(Peer reviewed)